HIVR4P 2018: From Research to Impact Conference Summary and Highlights
Por:
Shacklett, BL, Blanco, J, Hightow-Weidman, L, Mgodi, N, Alcami, J, Buchbinder, S, Chirenje, M, Dabee, S, Diallo, M, Dumchev, K, Herrera, C, Levy, ME, Gayo, EM, Makoah, NA, Mitchell, KM, Mugwanya, K, Reddy, K, Rodriguez, ML, Rodriguez-Garcia, M, Shover, CL, Shrivastava, T, Tomaras, G, Van Diepen, M, Walia, M, Warren, M, Manrique, A, Thyagarajan, B and Torri, T
Publicada:
1 jul 2019
Ahead of Print:
1 may 2019
Resumen:
The HIV Research for Prevention (HIVR4P) conference is dedicated to advancing HIV prevention research, responding to a growing consensus that effective and durable prevention will require a combination of approaches as well as unprecedented collaboration among scientists, practitioners, and community workers from different fields and geographic areas. The conference theme in 2018, "From Research to Impact," acknowledged an increasing focus on translation of promising research findings into practical, accessible, and affordable HIV prevention options for those who need them worldwide. HIVR4P 2018 was held in Madrid, Spain, on 21-25 October, with >1,400 participants from 52 countries around the globe, representing all aspects of HIV prevention research and implementation. The program included 137 oral and 610 poster presentations. This article presents a brief summary of highlights from the conference. More detailed information, complete abstracts as well as webcasts and daily Rapporteur summaries may be found on the conference website.
Filiaciones:
Shacklett, BL:
Univ Calif Davis, Med Microbiol & Immunol, Davis, CA 95616 USA
:
IGTP, IrsiCaixa, Barcelona, Spain
Univ Vic UCC, Chair AIDS & Related Illnesses, Ctr Hlth & Social Care Res CESS, Fac Med, Barcelona, Spain
Hightow-Weidman, L:
Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USA
Mgodi, N:
Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe
Alcami, J:
Inst Salud Carlos III, AIDS Immunopathol Unit, Madrid, Spain
Buchbinder, S:
San Francisco Dept Publ Hlth, San Francisco, CA USA
Chirenje, M:
Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe
Dabee, S:
Univ Cape Town, Div Med Virol, Cape Town, South Africa
Diallo, M:
Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada
Dumchev, K:
Res Ukrainian Inst Publ Hlth Policy, Kiev, Ukraine
Herrera, C:
Imperial Coll London, Dept Med, Fac Med, London, England
Levy, ME:
George Washington Univ, Dept Epidemiol & Biostat, Washington, DC USA
Gayo, EM:
Univ Autonoma Madrid, Dept Immunol, Hosp Univ La Princesa, Madrid, Spain
Makoah, NA:
Natl Inst Communicable Dis, Ctr HIV & STIs, Johannesburg, South Africa
Mitchell, KM:
Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England
Imperial Coll London, HPTN Modelling Ctr, London, England
Mugwanya, K:
Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
Reddy, K:
Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Sch Clin Med, Johannesburg, South Africa
:
IGTP, IrsiCaixa, Barcelona, Spain
Rodriguez-Garcia, M:
Geisel Sch Med Dartmouth, Dept Physiol & Neurobiol, Lebanon, NH USA
Shover, CL:
Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA
Shrivastava, T:
Translat Hlth Sci & Technol Inst, Dept Infect & Immunol, Faridabad, India
Tomaras, G:
Duke Univ, Dept Surg, Durham, NC USA
Duke Univ, Dept Immunol, Durham, NC USA
Duke Univ, Dept Mol Genet & Microbiol, Durham, NC USA
Van Diepen, M:
Univ Cape Town, Div Med Virol, Cape Town, South Africa
Walia, M:
Populat Council, 1230 York Ave, New York, NY 10021 USA
Warren, M:
AVAC, New York, NY USA
Manrique, A:
Global HIV Vaccine Enterprise, New York, NY USA
Thyagarajan, B:
Global HIV Vaccine Enterprise, New York, NY USA
Torri, T:
Int AIDS Soc, 23 Ave France, CH-1202 Geneva, Switzerland
Green Published, Green Submitted, hybrid
|